10K-2001 HEMISPHERX BIOPHARMA INC.

Company

AIM ImmunoTech Inc.

Filed

April 9, 2002

Period of Report

December 31, 2001

Accession Number

0000946644-02-000002

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →